Advanced search
Publication Cover
Postgraduate Medicine Volume 123, 2011 - Issue 3
Submit an article Journal homepage
207
Views
6
CrossRef citations to date
0
Altmetric
Clinical Features

Effects of Open-Label Lisdexamfetamine Dimesylate on Self-Reported Quality of Life in Adults with ADHD

Matthew Brams Principal Investigator, Bayou City Research, Houston, TXCorrespondence[email protected]
, MD,
John Giblin President/CEO/Medical Director, Clinical Study Centers, LLC, Little Rock, AR
, MD,
Maria Gasior Clinical Medicine Director, Shire Development Inc., Wayne, PA
, MD, PhD,
Joseph Gao Director, Biostatistics, Clinical Development Operations & Biometrics, Shire Development Inc., Wayne, PA
, PhD &
Timothy Wigal Associate Professor, Department of Pediatrics, University of California, Irvine, Irvine, CA
, PhD
Pages 99-108 | Published online: 13 Mar 2015

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Lisa L Weyandt, Danielle R Oster, Marisa E Marraccini, Bergljot Gyda Gudmundsdottir, Bailey A Munro, Brynheld Martinez Zavras & Ben Kuhar. (2014) Pharmacological interventions for adolescents and adults with ADHD: stimulant and nonstimulant medications and misuse of prescription stimulants. Psychology Research and Behavior Management 7, pages 223-249.
Read now

Articles from other publishers (5)

Evelina A. Zimovetz, Alain Joseph, Rajeev Ayyagari & Josephine A. Mauskopf. (2017) A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK. The European Journal of Health Economics 19:1, pages 21-35.
Crossref
Nichea S. Spillane, Lisa Weyandt, Danielle Oster & Hayley Treloar. (2017) Social contextual risk factors for stimulant use among adolescent American Indians. Drug and Alcohol Dependence 179, pages 167-173.
Crossref
Merete B. Bjerrum, Preben U. Pedersen & Palle Larsen. (2017) Living with symptoms of attention deficit hyperactivity disorder in adulthood: a systematic review of qualitative evidence. JBI Database of Systematic Reviews and Implementation Reports 15:4, pages 1080-1153.
Crossref
Jadwiga Najib, Dexter WimerJulie ZengKristina W LamNatalya RomanyakEva Paige MorganAnu Thadavila. (2017) Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder. Journal of Central Nervous System Disease 9, pages 117957351772809.
Crossref
Lenard A Adler, Bryan Dirks, Patrick Deas, Aparna Raychaudhuri, Matthew Dauphin, Keith Saylor & Richard Weisler. (2013) Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study. BMC Psychiatry 13:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.